m+Medelevator.RU
← Поиск публикаций
Ophthalmic genetics · 2026

Isolated rod-cone dystrophy in homozygous IFT140 missense allele p.Tyr923Asp.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Eiselen Carl, Shanks Morag, Sperring Sian, Cehajic-Kapetanovic Jasmina

Аннотация

OBJECTIVE: IFT140 encodes a core intraflagellar transport protein essential for ciliary function. While biallelic IFT140 variants typically cause syndromic ciliopathies such as Mainzer-Saldino syndrome, isolated retinal phenotypes are increasingly recognized. We describe two affected siblings from a consanguineous Pakistani family with lifelong nyctalopia and progressive peripheral field loss associated with a homozygous IFT140 missense variant, c.2767T > G (p.Tyr923Asp) (NM_014714.3).

METHOD: Detailed ophthalmic evaluation included multimodal retinal imaging, electrodiagnostics, and microperimetry. Systemic screening and segregation analysis were undertaken.

RESULT: Both brothers exhibited classical rod-cone dystrophy with parafoveal hyperautofluorescent rings and parafoveal ellipsoid zone loss on OCT. Electroretinography confirmed reduced dark and light-adapted responses. Systemic evaluation at diagnosis and eight years later, including renal, skeletal, and auditory assessments, was normal. Segregation testing demonstrated autosomal-recessive inheritance, with both parents heterozygous and the unaffected sister a non-carrier. The variant, absent from gnomAD, now meets Association for Clinical Genomic Science (ACGS) criteria for Likely Pathogenic classification.

CONCLUSION: Homozygosity for the likely pathogenic IFT140 c.2767T > G (p.Tyr923Asp) causes isolated rod-cone dystrophy without systemic involvement. This report expands the IFT140 phenotypic spectrum, emphasizing the importance of precise molecular diagnosis for variant reclassification, genetic counseling, and gene therapy eligibility.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты